0001477932-21-003575.txt : 20210525 0001477932-21-003575.hdr.sgml : 20210525 20210525060140 ACCESSION NUMBER: 0001477932-21-003575 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161117 FILED AS OF DATE: 20210525 DATE AS OF CHANGE: 20210525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson Robert Steven CENTRAL INDEX KEY: 0001412747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55908 FILM NUMBER: 21957267 MAIL ADDRESS: STREET 1: 7633 E. 63RD PLACE, #220 CITY: TULSA STATE: OK ZIP: 74133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp. CENTRAL INDEX KEY: 0001643301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371765151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805-824-0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 FORMER COMPANY: FORMER CONFORMED NAME: Makkanotti Group Corp. DATE OF NAME CHANGE: 20150526 4 1 form4.xml FORM 4 X0306 4 2016-11-17-05:00 false 0001643301 Cure Pharmaceutical Holding Corp. CURR 0001412747 Davidson Robert Steven 1620 BEACON PLACE OXNARD CA 93022 true true false false Chief Executive Officer Common Stock 2018-10-10-05:00 4 G false 25000 0.00 D 524756 D Common Stock 2019-07-01-05:00 4 A false 31250 0.00 A 556006 D Common Stock 2021-05-24-05:00 4 P false 6443 0.689 A 562449 D Stock Option 0.74 2016-11-07-05:00 4 A false 354000 0.00 A 2028-04-06-05:00 Common Stock 354000 354000 D Stock Option 0.61 2018-05-07-05:00 4 A false 68750 0.00 A 2028-05-07-05:00 Common Stock 68750 68750 D Stock Option 3.40 2019-04-11-05:00 4 A false 225000 0.00 A 2029-04-11-05:00 Common Stock 225000 225000 D The reporting person transferred 25,000 shares of common stock to his son as a bona-fide gift. This late filing is due to an inadvertent administrative error and not any error of the reporting person. Represents shares of common stock received upon vesting of a restricted stock award. This late filing is due to an inadvertent administrative error and not any error of the reporting person. This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.68422 to $0.69350. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points. The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person. /s/ Robert Davidson 2021-05-25-05:00